Trader Alert --- CVM

CEL-SCI Corporation. a biotechnology company. engages in research and
development of drugs and vaccines for the treatment of cancer and infectious
diseases. The company's primary product Multikine is a patented
immunotherapeutic agent consisting of a mixture of naturally occurring
cytokines under phase II clinical trail for the treatment of cancer. It also
develops CEL-1000 peptide product with its Ligand Epitope Antigen
Presentation System technology which is under preclinical stage for the
protection/treatment of animals against herpes. viral encephalitis.
and cancer. The company markets its products to cancer centers.
and clinics involved in immunotherapy. CEL-SCI was founded in 1983 and is
based in Vienna.